Adrenocortical carcinoma is a lynch syndrome-associated cancer

Journal of Clinical Oncology

Volumn 31, Issue 24, 2013, Pages 3012-3018

  Raymond, Victoria M ^a   Everett, Jessica N ^a   Furtado, Larissa V ^a   Gustafson, Shanna L ^a   Jungbluth, Chelsy R ^b   Gruber, Stephen B ^c   Hammer, Gary D ^a   Stoffel, Elena M ^a   Greenson, Joel K ^a   Giordano, Thomas J ^a   Else, Tobias ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

^b CHILDREN S HOSPITALS AND CLINICS OF MINNESOTA   (United States)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MISMATCH REPAIR PROTEIN;

ADOLESCENT; ADRENAL CORTEX CARCINOMA; ADULT; AGED; CANCER SCREENING; CHILD; CLINICAL EVALUATION; CLINICAL GENETICS; CONFERENCE PAPER; DISEASE ASSOCIATION; FAMILY HISTORY; FEMALE; GENE MUTATION; GENETIC COUNSELING; GERMLINE MUTATION; HEREDITARY NONPOLYPOSIS COLORECTAL CANCER; HUMAN; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MICROSATELLITE INSTABILITY; MISMATCH REPAIR; PREVALENCE; PRIORITY JOURNAL; RISK ASSESSMENT; ADRENAL CORTEX TUMOR; ARTICLE; GENETIC PREDISPOSITION; GENETICS; MIDDLE AGED; PATHOLOGY; PROSPECTIVE STUDY;

ADRENAL CORTEX NEOPLASMS; ADRENOCORTICAL CARCINOMA; ADULT; COLORECTAL NEOPLASMS, HEREDITARY NONPOLYPOSIS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84887235975     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2012.48.0988     Document Type: Conference Paper

References (41)

1. Dinh TA, Rosner BI, Atwood JC, et al: Health benefits and cost-effectiveness of primary genetic screening for Lynch syndrome in the general population. Cancer Prev Res (Phila) 4:9-22, 2011
2. Stoffel E, Mukherjee B, Raymond VM, et al: Calculation of risk of colorectal and endometrial cancer among patients with Lynch syndrome. Gastroenterology 137:1621-1627, 2009
3. Aarnio M, Mecklin JP, Aaltonen LA, et al: Life-time risk of different cancers in hereditary nonpolyposis colorectal cancer (HNPCC) syndrome. Int J Cancer 64:430-433, 1995
4. Aarnio M, Sankila R, Pukkala E, et al: Cancer risk in mutation carriers of DNA-mismatch-repair genes. Int J Cancer 81:214-218, 1999
5. Järvinen HJ, Aarnio M, Mustonen H, et al: Controlled 15-year trial on screening for colorectal cancer in families with hereditary nonpolyposis colorectal cancer. Gastroenterology 118:829-834, 2000
6. Win AK, Young JP, Lindor NM, et al: Colorectal and other cancer risks for carriers and noncarriers from families with a DNA mismatch repair gene mutation: A prospective cohort study. J Clin Oncol 30:958-964, 2012
7. Kebebew E, Reiff E, Duh QY, et al: Extent of disease at presentation and outcome for adrenocortical carcinoma: Have we made progress? World J Surg 30:872-878, 2006
8. Ribeiro RC, Sandrini F, Figueiredo B, et al: An inherited p53 mutation that contributes in a tissuespecific manner to pediatric adrenal cortical carcinoma. Proc Natl Acad Sci U S A 98:9330-9335, 2001
9. Fraumeni JF Jr, Miller RW: Adrenocortical neoplasms with hemihypertrophy, brain tumors, and other disorders. J Pediatr 70:129-138, 1967
10. Varley JM: Germline TP53 mutations and Li-Fraumeni syndrome. Hum Mutat 21:313-320, 2003
11. Varley JM, McGown G, Thorncroft M, et al: Are there low-penetrance TP53 alleles? Evidence from childhood adrenocortical tumors. Am J Hum Genet 65:995-1006, 1999
12. Herrmann LJ, Heinze B, Fassnacht M, et al: TP53 germline mutations in adult patients with adrenocortical carcinoma. J Clin Endocrinol Metab 97:E476-E485, 2012
13. Raymond VM, Else T, Everett JN, et al: Prevalence of germline TP53 mutations in a prospective series of unselected patients with adrenocortical carcinoma. J Clin Endocrinol Metab 98:E119-E125, 2013
14. Waldmann J, Fendrich V, Habbe N, et al: Screening of patients with multiple endocrine neoplasia type 1 (MEN-1): A critical analysis of its value. World J Surg 33:1208-1218, 2009
15. Langer P, Cupisti K, Bartsch DK, et al: Adrenal involvement in multiple endocrine neoplasia type 1. World J Surg 26:891-896, 2002
16. Else T: Association of adrenocortical carcinoma with familial cancer susceptibility syndromes. Mol Cell Endocrinol 351:66-70, 2012
17. Chompret A, Abel A, Stoppa-Lyonnet D, et al: Sensitivity and predictive value of criteria for p53 germline mutation screening. J Med Genet 38:43-47, 2001
18. Bacher JW, Flanagan LA, Smalley RL, et al: Development of a fluorescent multiplex assay for detection of MSI-high tumors. Dis Markers 20:237-250, 2004
19. Aaltonen LA, Peltomäki P, Leach FS, et al: Clues to the pathogenesis of familial colorectal cancer. Science 260:812-816, 1993
20. Ionov Y, Peinado MA, Malkhosyan S, et al: Ubiquitous somatic mutations in simple repeated sequences reveal a new mechanism for colonic carcinogenesis. Nature 363:558-561, 1993
21. Thibodeau SN, Bren G, Schaid D: Microsatellite instability in cancer of the proximal colon. Science 260:816-819, 1993
22. Boland CR, Thibodeau SN, Hamilton SR, et al: A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: Development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res 58: 5248-5257, 1998
23. Umar A, Boland CR, Terdiman JP, et al: Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. J Natl Cancer Inst 96: 261-268, 2004
24. Nakagawa H, Lockman JC, Frankel WL, et al: Mismatch repair gene PMS2: Disease-causing germline mutations are frequent in patients whose tumors stain negative for PMS2 protein, but paralogous genes obscure mutation detection and interpretation. Cancer Res 64:4721-4727, 2004
25. Beamer LC, Grant ML, Espenschied CR, et al: Reflex immunohistochemistry and microsatellite instability testing of colorectal tumors for Lynch syndrome among US cancer programs and follow-up of abnormal results. J Clin Oncol 30: 1058-1063, 2012
26. National Comprehensive Cancer Network: National Comprehensive Cancer Network Web site. http://www.nccn.org
27. Chen S, Wang W, Lee S, et al: Prediction of germline mutations and cancer risk in the Lynch syndrome. JAMA 296:1479-1487, 2006
28. Hampel H, Frankel W, Panescu J, et al: Screening for Lynch syndrome (hereditary nonpolyposis colorectal cancer) among endometrial cancer patients. Cancer Res 66:7810-7817, 2006
29. Hampel H, Frankel WL, Martin E, et al: Screening for the Lynch syndrome (hereditary nonpolyposis colorectal cancer). N Engl J Med 352: 1851-1860, 2005
30. Moreira L, Balaguer F, Lindor N, et al: Identification of Lynch syndrome among patients with colorectal cancer. JAMA 308:1555-1565, 2012
31. Evaluation of Genomic Applications in Practice and Prevention (EGAPP) Working Group: Recommendations from the EGAPP Working Group: Genetic testing strategies in newly diagnosed individuals with colorectal cancer aimed at reducing morbidity and mortality from Lynch syndrome in relatives. Genet Med 11:35-41, 2009
32. Meyer LA, Broaddus RR, Lu KH: Endometrial cancer and Lynch syndrome: Clinical and pathologic considerations. Cancer Control 16:14-22, 2009
33. Lynch HT, Shaw MW, Magnuson CW, et al: Hereditary factors in cancer: Study of two large Midwestern kindreds. Arch Intern Med 117:206-212, 1966
34. Berends MJ, Cats A, Hollema H, et al: Adrenocortical adenocarcinoma in an MSH2 carrier: Coincidence or causal relation? Hum Pathol 31:1522-1527, 2000
35. Karamurzin Y, Zeng Z, Stadler ZK, et al: Unusual DNA mismatch repair-deficient tumors in Lynch syndrome: A report of new cases and review of the literature. Hum Pathol, 2012
36. Medina-Arana V, Delgado L, González L, et al: Adrenocortical carcinoma, an unusual extracolonic tumor associated with Lynch II syndrome. Fam Cancer 10:265-271, 2011
37. Broaddus RR, Lynch PM, Lu KH, et al: Unusual tumors associated with the hereditary nonpolyposis colorectal cancer syndrome. Mod Pathol 17: 981-989, 2004
38. Okkels H, Lindorff-Larsen K, Thorlasius-Ussing O, et al: MSH6 mutations are frequent in hereditary nonpolyposis colorectal cancer families with normal pMSH6 expression as detected by immunohistochemistry. Appl Immunohistochem Mol Morphol 20:470-477, 2012
39. Hendriks YM, Wagner A, Morreau H, et al: Cancer risk in hereditary nonpolyposis colorectal cancer due to MSH6mutations: Impact on counseling and surveillance. Gastroenterology 127:17-25, 2004
40. Weissman SM, Burt R, Church J, et al: Identification of individuals at risk for Lynch syndrome using targeted evaluations and genetic testing: National Society of Genetic Counselors and the Collaborative Group of the Americas on Inherited Colorectal Cancer joint practice guideline. J Genet Couns 21:484-493, 2012
41. Plocharczyk EF, Frankel WL, Hampel H, et al: Mismatch repair protein deficiency is common in sebaceous neoplasms and suggests the importance of screening for lynch syndrome. Am J Dermatopathol, 2012